GE HealthCare to Acquire Imactis

January 9, 2023—GE HealthCare announced it has entered into an agreement to acquire Imactis, a France-based company focused on CT interventional guidance solutions in various care areas. The consummation of the transaction is subject to customary closing conditions, including review by the relevant governmental authorities in France. Financial details of the transaction have not been disclosed publicly.

According to GE HealthCare, Imactis was founded in 2009 by Stephane Lavallee and Lionel Carrat, who created CT-Navigation. CT-Navigation is an ergonomic universal solution that provides stereotactic needle guidance, enabling intuitive preplanning and continuous control throughout a wide range of procedures, from diagnosis to treatment. It includes an integrated workstation, guidance software, and disposable procedure kit.

Imactis’ CT-Navigation is currently approved under the European Union’s Medical Devices Regulation and has received FDA clearance for use in the United States.

GE HealthCare plans to expand the technology to its image-guided therapy business. Interventional guidance is increasing because of the growing worldwide need across an array of care areas including oncology, cardiology, urology, nephrology, and gastroenterology, noted the company.

Jan Makela, President and CEO of Imaging, GE HealthCare, commented in the press release, “We’re thrilled to take this step in strengthening our interventional guidance offering for patients and customers. The Imactis CT-Navigation system is designed to improve workflow for interventional radiologists and hospitals by increasing procedural accuracy while helping to reduce procedure time and radiation dose for patients and physicians. It is an innovative navigation solution for image-guided percutaneous procedures that aims for better patient outcomes by reducing variability for simple and complex procedures and improving reproducibility.”

Imactis President and CEO Pierre Olivier added, “The timing to join GE HealthCare is perfect. Our solution, which is already deployed in leading health care systems in Europe and the United States, is ready to scale and become a standard of care thanks to GE HealthCare’s market access. Our product development team also sees significant opportunities to integrate our hardware and software into GE HealthCare solutions and make the workflow of the interventional radiologists and oncologists even simpler and faster.”